Tumors of the Eye and Ocular Adnexa - AFIP Atlas of Tumor Pathology
Vol. 3 Series 5
Descriptif détaillé : Tumors of the Eye and Ocular Adnexa - AFIP Atlas of Tumor Pathology.vol 3 series 5
What is the content of "Tumors of the Eye and Ocular Adnexa - AFIP Atlas of Tumor Pathology Volume 3 Series 5" ?
This book is part of the Fifth Series of the AFIP Atlases of Tumor and Non-Tumor Pathology is enriched with the most recent developments in the diagnosis and treatment of ophthalmic tumors, illustrated with a profusion of images related to ophtalmic pathology.
The aim of this volume is to stress the importance of a correct diagnosis, as well as to provide a guide for the ophthalmic surgeon to a treatment plan that will simultaneously preserve the patient's vision.
Who are the authors of "Tumors of the Eye and Ocular Adnexa - AFIP Atlas of Tumor Pathology Volume 3 Series 5" ?
Robert Folberg, MD, became Founding Dean of the Oakland University William Beaumont School of Medicine in September, 2008. He came to the School of Medicine from the University of Illinois at Chicago (UIC) where he was the Frances B. Geever Professor of Pathology and Head of the Department of Pathology. He was also a Professor of Ophthalmology and Visual Science at UIC.
Dr. Folberg is a clinician scientist who was funded for 20 years by the National Institutes of Health (NIH) to study the biology of uveal melanoma. While head of pathology at UIC, he served as deputy director of the University of Illinois Cancer Center from 2003 to 2005. He has published more than 200 original articles and book chapters.
He is recognized for innovation in medical education and continues to teach pathology of the eye to medical institutions within and outside the United States. He also continues his consultation practice of ophthalmic pathology at Beaumont Health where he is William Beaumont Hospital's Chief Academic Officer.
Patricia Chevez-Barrios, MD.
She has current appointments of adjunct professor in the Department of Pathology at The University of Texas MD Anderson Cancer Center and Department of Ophthalmology at the Baylor College of Medicine. Dr. Chévez- Barrios assumed her current positions at Methodist in 2004.
The main research interest of Dr. Chévez-Barrios and her laboratory is the study of retinoblastoma, including cancer stem cells, suicide gene therapy for retinoblastoma, the study of metastatic properties of retinoblastoma and preclinical models of the tumor. Other topics of interest are ocular gene therapy, cataractogenesis, vascular proliferation in hypoxic ocular diseases and corneal diseases.
Dr. Chevez-Barrios’ laboratory is currently participating in the project of gene therapy for Retinoblastomas in collaboration with the Texas Children’s Cancer Center and the Center for Gene Therapy of Texas Children's Hospital, and Baylor College of Medicine.
Amy Y. Lin, MD
Dr. Lin is the Chief Ophthalmic Pathologist at the University of Illinois College of Medicine-Chicago with a strong interest in understanding the pathologic basis of ocular disease. She serves as course director for the year-long College of Medicine course on General and Systemic Pathology. Dr. Lin is actively involved in a number of research projects with ophthalmology investigators. She joined the Department in 2007.
Tatyana Milman, MD
Associate Professor of Pathology, Wills Eye Institute/Thomas Jefferson University.
Tatyana Milman, MD, is a physician in the Ocular Pathology Service at Wills Eye Hospital and an Associate Professor, Ophthalmology and Associate Professor, Pathology, Anatomy, and Cell Biology, Sidney Kimmel Medical College of Thomas Jefferson University (SKMC), working as an Ophthalmic Pathologist and Comprehensive Ophthalmologist.